Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

University of Toronto

$154,245.00

Can COVID-19 and maternal antibodies to SARS-CoV-2 be transmitted through human milk? Implications for breastfeeding and human milk banking

FY 2020-21

Summary
Protecting the health of newborns is of utmost importance, particularly true at the time of a pandemic such as COVID-19. Human milk, the optimal infant nutrition, modulates the developing human virome and provides protection against infectious diseases especially those of the respiratory and gastrointestinal tracts. There is emerging evidence that SARS-CoV-2, the virus responsible for COVID-19, may be found in human milk which has resulted in conflicting advice from professional groups recommending caution for breastfeeding while a mother is COVID-19 positive. Even less is known about SARS-CoV-2 specific antibodies that may be present in human milk, potentially offering immunoprotection to infants. For vulnerable infants, human donor milk provides an important bridge to mother's milk during hospitalization that helps to protect against neonatal morbidities. This donor milk is provided globally by more than 450 milk banks. Past global epidemics, such as HIV/AIDS, have had devastating effects on breastfeeding and milk banking as a result of social, policy and public health responses to perceived risks. There is a critical, time-sensitive need to develop evidence-based guidance on breastfeeding and human milk banking during the COVID-19 pandemic. This project aims to quickly and efficiently determine the SARS-CoV-2 transmissibility in human milk and measure the associated antibodies along with the impact of thermal pasteurization on SARS-CoV-2 infectivity. Our newly assembled team of experts in breastfeeding, human milk banking, infectious disease and molecular virology will immediately redirect parts of their established research programs including established infrastructure and personnel to accelerate the availability of critical time-sensitive evidence to guide public health recommendations about breastfeeding, handling of raw breastmilk by mothers and front-line workers in hospitals and in donor human milk banks.
Program
Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
430017
Name
O'Connor Deborah L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
COVID-19 Rapid Research - Clinical Management & Health System Interventions
Projecttitle
Can COVID-19 and maternal antibodies to SARS-CoV-2 be transmitted through human milk? Implications for breastfeeding and human milk banking
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$154,245
Cihrequipment2
$0
Programname2
Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions
Keyworddelim
Breastfeeding; Covid-19; Donor Human Milk; Human Milk; Milk Banking
Abstract
Protecting the health of newborns is of utmost importance, particularly true at the time of a pandemic such as COVID-19. Human milk, the optimal infant nutrition, modulates the developing human virome and provides protection against infectious diseases especially those of the respiratory and gastrointestinal tracts. There is emerging evidence that SARS-CoV-2, the virus responsible for COVID-19, may be found in human milk which has resulted in conflicting advice from professional groups recommending caution for breastfeeding while a mother is COVID-19 positive. Even less is known about SARS-CoV-2 specific antibodies that may be present in human milk, potentially offering immunoprotection to infants. For vulnerable infants, human donor milk provides an important bridge to mother's milk during hospitalization that helps to protect against neonatal morbidities. This donor milk is provided globally by more than 450 milk banks. Past global epidemics, such as HIV/AIDS, have had devastating effects on breastfeeding and milk banking as a result of social, policy and public health responses to perceived risks. There is a critical, time-sensitive need to develop evidence-based guidance on breastfeeding and human milk banking during the COVID-19 pandemic. This project aims to quickly and efficiently determine the SARS-CoV-2 transmissibility in human milk and measure the associated antibodies along with the impact of thermal pasteurization on SARS-CoV-2 infectivity. Our newly assembled team of experts in breastfeeding, human milk banking, infectious disease and molecular virology will immediately redirect parts of their established research programs including established infrastructure and personnel to accelerate the availability of critical time-sensitive evidence to guide public health recommendations about breastfeeding, handling of raw breastmilk by mothers and front-line workers in hospitals and in donor human milk banks.
Competitiondate
202005
Approvedterm2
1 yr 0 mth
Pinamesdelim
O'Connor, Deborah L; Poutanen, Susan M; Unger, Sharon
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $154,245~ $0~
University of Toronto - $154,245 Grant (2020-21) | Canada Spends